// STATE LEGISLATION TRACKER

Minnesota SF 4069: Veterinary medicine and veterinary technology practice provisions modifications

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Minnesota
Bill: SF 4069
Session: 2025-2026
Filed: 2026-03-02
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

This bill is about veterinary medicine and veterinary technology practice rules in Minnesota, not human health care. Based on the title, subjects, and status, it has no direct peptide-ecosystem relevance for compounded peptides, off-label human prescribing, telehealth peptide clinics, NPs, naturopaths, or FDA 503A/503B compounding.

Key Points

No direct change to human compounded peptide access
No apparent change to NP or naturopath peptide prescribing
No apparent change to human telehealth peptide care
No FDA 503A or 503B compounding issue flagged
Veterinary drug rules should not be read as human peptide policy

What to Watch For

Note This appears limited to animal care and veterinary practice rules.

Note Do not treat veterinary telemedicine or drug rules as guidance for human peptide prescribing.

Note Companion bill HF3718 appears to have carried the policy forward after SF4069 was postponed.

Where the Bill Stands

SF4069 was indefinitely postponed after HF3718 was substituted, so this Senate bill did not move forward as the active vehicle.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws